Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 350 | 310 | 303 | 349 | 229 |
| Operating Income | -350 | -310 | -303 | -349 | -229 |
| Other Income | 4 | 310 | 303 | 8 | 4 |
| Pre-tax Income | -347 | N/A | N/A | -341 | -224 |
| Net Income Continuous | -348 | -304 | -299 | -341 | -224 |
| Net Income | $-348 | $-304 | $-299 | $-341 | $-224 |
| EPS Basic Total Ops | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 |
| EPS Basic Continuous Ops | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 |
| EPS Diluted Total Ops | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 |
| EPS Diluted Continuous Ops | -0.04 | -0.04 | 0.00 | -0.04 | -0.02 |
| EBITDA(a) | $-339 | $-302 | $-304 | $-335 | $-218 |